Volume8, Issue0 (2022) | undefined

Hepatoma Research

Search Log In

Editor-in-Chief: Guang-Wen Cao

Indexing: ESCI, CAS, Scopus, Wanfang Data, CNKI, Dimensions, Embase, ASCI,

Journal Rank: CiteScore 3.5 - Impact Factor 1.2, Q3 (Gastroenterology & Hepatology)

Median time to first editorial decision: 10 days

Hot Keywords

Hepatocellular carcinoma HCC Liver Cancer Liver tumors Hepatoblastoma Cholangiocarcinoma Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis Hepatitis B; Hepatitis C Immunotherapy Systemic treatment Liver transplantation Liver resection Surgical Management Surveillance Epidemiology Molecular mechanisms Tumor microenvironment Biomarker Stem cell

Home

About

Publish with us

Articles

Special Topics

Volumes

Features

Home Articles Special Topics Volumes Webinars Videos

Hepatoma Research

Editor-in-Chief: Guang-Wen Cao

Journal Rank: CiteScore 3.5 - Impact Factor 1.2, Q3 (Gastroenterology & Hepatology)

Median time to first editorial decision: 10 days

Home Articles Special Topics Volumes Webinars Videos

Home Volumes

Volume

Table of Contents (80 articles)

Radiological imaging and non-surgical local treatments for cholangiocarcinoma

Angelo Della Corte, ... Francesco De Cobelli

Histopathology of hepatocellular carcinoma - when and what

Doreen Maria Gisder, ... Iris Tischoff

Robotic donor hepatectomy: a niche advancement or the way forward? A perspective from the world’s largest center

Mark Sturdevant, ... Dieter Broering

Tenofovir disoproxil fumarate is not associated with a lower risk of hepatocellular carcinoma compared to entecavir in patients with chronic hepatitis B

Hye Won Lee, ... Seung Up Kim

Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma

Andrew J. Woerner, ... Guy E. Johnson

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Chimaobi M. Anugwom, ... Jose D. Debes

Experience of living donor liver transplantation for hepatocellular carcinoma in the University of Hong Kong Hospital

Janice Hoi Man Mok, ... Kenneth Siu Ho Chok

Molecular mechanisms of liver carcinogenesis related to metabolic syndrome

Claudia Campani, ... Jean-Charles Nault

Epidemiology of cholangiocarcinoma

Federica Turati, ... Carlo La Vecchia

Hepatocellular carcinoma surveillance: current practice and future directions

Joseph C. Ahn, ... Ju Dong Yang

Association of human leukocyte antigen-DR-DQ-DP haplotypes with the risk of hepatitis B virus-related hepatocellular carcinoma

Yifan Chen, ... Guangwen Cao

Hepatocellular carcinoma on the background of nonalcoholic fatty liver disease: epidemiological update

Elvire Desjonqueres, ... Elia Gigante

Role of locoregional therapies in the management of patients with hepatocellular carcinoma

Janet Wui Cheung Kung, ... Kelvin Kwok Chai Ng

Liver cancer understaging in liver transplantation in the current era of radiologic imaging and newer generation locoregional therapies

Hannah M. Lee, ... Richard K. Sterling

Tumor microenvironment and immunology of cholangiocarcinoma

Massimiliano Cadamuro, ... Mario Strazzabosco

Safety and efficacy of DEM-TACE performed with drug-eluting microspheres smaller than 300 μm in patients with HCC and TIPS

Pierleone Lucatelli, ... Carlo Catalano

Overview of methodologies and statistical strategies in observational studies and meta-analyses on the risk of hepatocellular carcinoma in patients with chronic hepatitis B on entecavir or tenofovir therapy

Terry Cheuk-Fung Yip, ... Grace Lai-Hung Wong

Protective benefit of minimally invasive liver surgery for hepatocellular carcinoma prior to transplant

Simone Khouzam, ... Salvatore Gruttadauria

Repeat laparoscopic anatomical liver resection in a hepatocellular carcinoma patient: a case report

Kazuharu Igarashi, ... Go Wakabayashi

The pros and cons of biological effects of herbs and herb-derived compounds on liver tumorigenesis

Mohamad Khalil, ... Piero Portincasa

Promise and pitfalls of new viral biomarkers for hepatocellular carcinoma risk prediction in patients with chronic hepatitis B

Kali Zhou, ... Norah Terrault

A focused review on recent advances in diagnosis and management of fibrolamellar hepatocellular carcinoma

Mahmoud Aryan, ... Mohamed Shoreibah

Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C

Nikoletta M. Tagkou, ... Francesco Negro

Hepatitis B virus (HBV) and hepatocellular carcinoma (HCC) in sub-Saharan Africa: no room for complacency

Philippa C. Matthews, ... Anna Kramvis

Changes in hepatic fibrosis and incidence of HCC following direct-acting antiviral treatment of F3 chronic hepatitis c patients: a prospective observational study

Gamal Shiha, ... Nabiel N.H. Mikhail

The role of minimally invasive surgery in the treatment of HCC

Gianluca Cassese, ... Roberto Ivan Troisi

Minimally invasive surgery for HCC

Cassese Gianluca, ... Ho-Seong Han

The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time

Matteo Renzulli, ... Rita Golfieri

Liver tumors in children

Daniel C. Aronson, ... Piotr Czauderna

Cholangiocarcinoma: early detection and screening in high-risk population

Sergio Muñoz-Martínez, ... Alejandro Forner

Liver transplantation for hepatoblastoma

Dimitrios N. Varvoglis, ... Georgios Tsoulfas

Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance

Qian Wan, ... Jose D. Debes

Alteration in immune function in patients with fatty liver disease

Stephanie N. Gregory, ... Zachary J. Brown

Sonography in surveillance for HCC in NAFLD patients

Pompilia Radu

Pompilia Radu

, ... Jean Francois Dufour

Cancer stem cell-mediated therapeutic resistance in hepatocellular carcinoma

Mei-Mei Li, ... Ming Liu

Ming Liu

Old-fashioned and newly discovered biomarkers: the future of NAFLD-related HCC screening and monitoring

Roberto Piciotti, ... Paola Dongiovanni

Paola Dongiovanni

Artificial intelligence and its role in guiding liver-directed therapy for hepatocellular carcinoma: Is it ready for prime time?

Elena Panettieri

Elena Panettieri

, ... Agostino Maria De Rose

Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities

Sandi Kwee

Sandi Kwee

, ... Xin Chen

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease patients

Emily Truong, ... Mazen Noureddin

Artificial intelligence and its role in guiding liver-directed therapy for hepatocellular carcinoma: Is it ready for prime time?

Elena Panettieri

Elena Panettieri

, ... Agostino Maria De Rose

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease patients

Emily Truong, Mazen Noureddin

Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance

Qian Wan, ... Jose D. Debes

Sonography in surveillance for HCC in NAFLD patients

Pompilia Radu

Pompilia Radu

, Jean Francois Dufour

Old-fashioned and newly discovered biomarkers: the future of NAFLD-related HCC screening and monitoring

Roberto Piciotti, ... Paola Dongiovanni

Paola Dongiovanni

Cancer stem cell-mediated therapeutic resistance in hepatocellular carcinoma

Mei-Mei Li, ... Ming Liu

Ming Liu

Liver transplantation for hepatoblastoma

Dimitrios N. Varvoglis, ... Georgios Tsoulfas

Georgios Tsoulfas

Erratum: Defining the role of laparoscopic liver resection in elderly HCC patients: a propensity score matched analysis

Phoenix Wai Yan Wong, ... Chung Mau Lo

Erratum: Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy

Tina Boortalary, ... Hie-Won Hann

Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities

Sandi Kwee

Sandi Kwee

, Xin Chen

Alteration in immune function in patients with fatty liver disease

Stephanie N. Gregory, ... Zachary J. Brown

Cholangiocarcinoma: early detection and screening in high-risk population

Sergio Muñoz-Martínez, ... Alejandro Forner

Changes in hepatic fibrosis and incidence of HCC following direct-acting antiviral treatment of F3 chronic hepatitis c patients: a prospective observational study

Gamal Shiha

Gamal Shiha

, ... Nabiel N.H. Mikhail

Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C

Nikoletta M. Tagkou, ... Francesco Negro

The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time

Matteo Renzulli

Matteo Renzulli

, ... Rita Golfieri

The role of minimally invasive surgery in the treatment of HCC

Gianluca Cassese

Gianluca Cassese

, ... Roberto Ivan Troisi

A focused review on recent advances in diagnosis and management of fibrolamellar hepatocellular carcinoma

Mahmoud Aryan

Mahmoud Aryan

, ... Mohamed Shoreibah

Minimally invasive surgery for HCC

Cassese Gianluca, Ho-Seong Han

The pros and cons of biological effects of herbs and herb-derived compounds on liver tumorigenesis

Mohamad Khalil, ... Piero Portincasa

Liver tumors in children

Daniel C. Aronson, Piotr Czauderna

Repeat laparoscopic anatomical liver resection in a hepatocellular carcinoma patient: a case report

Kazuharu Igarashi, ... Go Wakabayashi

Liver cancer understaging in liver transplantation in the current era of radiologic imaging and newer generation locoregional therapies

Hannah M. Lee, ... Richard K. Sterling

Epidemiology of cholangiocarcinoma

Federica Turati, ... Carlo La Vecchia

Safety and efficacy of DEM-TACE performed with drug-eluting microspheres smaller than 300 μm in patients with HCC and TIPS

Pierleone Lucatelli, ... Carlo Catalano

Role of locoregional therapies in the management of patients with hepatocellular carcinoma

Janet Wui Cheung Kung

Janet Wui Cheung Kung

, Kelvin Kwok Chai Ng

Hepatocellular carcinoma on the background of nonalcoholic fatty liver disease: epidemiological update

Elvire Desjonqueres

Elvire Desjonqueres

, Elia Gigante

Promise and pitfalls of new viral biomarkers for hepatocellular carcinoma risk prediction in patients with chronic hepatitis B

Kali Zhou

Kali Zhou

, Norah Terrault

Hepatitis B virus (HBV) and hepatocellular carcinoma (HCC) in sub-Saharan Africa: no room for complacency

Philippa C. Matthews, Anna Kramvis

Anna Kramvis

Tenofovir disoproxil fumarate is not associated with a lower risk of hepatocellular carcinoma compared to entecavir in patients with chronic hepatitis B

Hye Won Lee, Seung Up Kim

Overview of methodologies and statistical strategies in observational studies and meta-analyses on the risk of hepatocellular carcinoma in patients with chronic hepatitis B on entecavir or tenofovir therapy

Terry Cheuk-Fung Yip

Terry Cheuk-Fung Yip

, ... Grace Lai-Hung Wong

Grace Lai-Hung Wong

Tumor microenvironment and immunology of cholangiocarcinoma

Massimiliano Cadamuro, ... Mario Strazzabosco

Hepatocellular carcinoma surveillance: current practice and future directions

Joseph C. Ahn, ... Ju Dong Yang

Protective benefit of minimally invasive liver surgery for hepatocellular carcinoma prior to transplant

Simone Khouzam, ... Salvatore Gruttadauria

Salvatore Gruttadauria

Association of human leukocyte antigen-DR-DQ-DP haplotypes with the risk of hepatitis B virus-related hepatocellular carcinoma

Yifan Chen, ... Guangwen Cao

Guangwen Cao

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Chimaobi M. Anugwom, ... Jose D. Debes

Experience of living donor liver transplantation for hepatocellular carcinoma in the University of Hong Kong Hospital

Janice Hoi Man Mok

Janice Hoi Man Mok

, ... Kenneth Siu Ho Chok

Kenneth Siu Ho Chok

Radiological imaging and non-surgical local treatments for cholangiocarcinoma

Angelo Della Corte, ... Francesco De Cobelli

Francesco De Cobelli

Histopathology of hepatocellular carcinoma - when and what

Doreen Maria Gisder

Doreen Maria Gisder

, ... Iris Tischoff

Molecular mechanisms of liver carcinogenesis related to metabolic syndrome

Claudia Campani, Jean-Charles Nault

Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma

Andrew J. Woerner, Guy E. Johnson

Robotic donor hepatectomy: a niche advancement or the way forward? A perspective from the world’s largest center

Mark Sturdevant, ... Dieter Broering

Actions for 0 selected articles

Hepatoma Research

ISSN 2454-2520 (Online) 2394-5079 (Print)

[email protected]

Navigation

Follow Us

LinkedIn
Twitter
Academia
Google Scholar

Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

[email protected]

Discover Content

Language Editing

Layout & Production

Graphical Abstracts

Video Abstracts

Conference Organizer

Strategic Collaborators

Follow OAE

© 2016-2026 OAE Publishing Inc., except certain content provided by third parties

Privacy Cookies Terms of Service

The current browser is not compatible

The following browsers are recommended for the best use experience

Chrome
Firefox
Safari

Only supports Mac
Edge